Aktie A1J8XY MUSCLEPHARM CORPORATION
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen MusclePharm Corporation

Aktien

A1J8XY

US6273352012

MSLP

Markt geschlossen - OTC Markets
Andere Börsenplätze
 21:28:56 03.04.2024 		% 5 Tage % 1. Jan.
0.000001 USD -99.92% Intraday Chart für MusclePharm Corporation 0.00% 0.00%
2023 Zweiter Antrag auf Verlängerung der Ausschließlichkeitsfrist für MusclePharm Corporation genehmigt CI
2023 FitLife Brands, Inc. (NasdaqCM:FTLF) hat die Übernahme von im Wesentlichen allen Vermögenswerten der MusclePharm Corporation (OTCPK:MSLP.Q) abgeschlossen. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation
FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).
Motion for Asset Sale Approved for MusclePharm Corporation
FitLife Brands, Inc. entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.
Stalking Horse Agreement Filed by MusclePharm Corporation
Musclepharm Corporation Announces Resignation of Paul Karr as Director
Second Amended Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation
First Amended Disclosure Statement Approved for MusclePharm Corporation
Bidding Procedure Approved for MusclePharm Corporation
Musclepharm Corporation Terminates Gary Shirshac as Chief Financial Officer
SEC Charges Former MusclePharm Executives with Accounting and Disclosure Fraud
First Amended Reorganization Plan and DIsclosure Statement Filed by MusclePharm Corporation
Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation
Motion for Asset Sale Filed by MusclePharm Corporation
First Motion for Exclusivity Period Extension Approved For MusclePharm Corporation
MusclePharm Corporation has withdrawn its IPO in the amount of $10 million.
First Motion for Exclusivity Period Extension Filed by MusclePharm Corporation
DIP Financing Approved for MusclePharm Corporation
Amended DIP Financing Approved for MusclePharm Corporation
Interim DIP Financing Approved for MusclePharm Corporation
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1J8XY Aktie
  4. Nachrichten MusclePharm Corporation
  5. Andere Sprachen